Pharmacy Week in Review: November 4, 2016

Nov 4, 2016

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Related Videos

Credit: wladimir1804 - stock.adobe.com

Women buying contraceptive pills in the pharmacy | Image credit: Antonioguillem - stock.adobe.com

Healthcare technology | Image credit: ipopba | stock.adobe.com

Gastroenterologist using digital x-ray of human intestine holographic scan projection 3D rendering | Image Credit: sdecoret - stock.adobe.com

Supreme Court | Image credit: steheap - stock.adobe.com

Pharmacists talking with a nurse | Image credit: Jacob Lund - stock.adobe.com

Healthcare technology | Image credit: ipopba | stock.adobe.com

Related Content

Efficacy of Upadacitinib Maintained for 3 Years for Those With Psoriatic Arthritis

Pharmacy Focus: Student Edition - Creatives in Pharmacy

One-Third of Adults With Type 2 Diabetes May Have Undetected, Symptomless Cardiovascular Disease

BONUS: American Association of Pharmacy Technicians Convention 2023

FDA Grants Fast Track Designation to Milvexian for Multiple Prospective Cardiovascular Indications

Obstructive Sleep Apnea May Have Significant Impact on Cognitive Decline in Middle-Aged Individuals

Efficacy of Upadacitinib Maintained for 3 Years for Those With Psoriatic Arthritis

Pharmacy Focus: Student Edition - Creatives in Pharmacy

One-Third of Adults With Type 2 Diabetes May Have Undetected, Symptomless Cardiovascular Disease

BONUS: American Association of Pharmacy Technicians Convention 2023

FDA Grants Fast Track Designation to Milvexian for Multiple Prospective Cardiovascular Indications

Obstructive Sleep Apnea May Have Significant Impact on Cognitive Decline in Middle-Aged Individuals

Efficacy of Upadacitinib Maintained for 3 Years for Those With Psoriatic Arthritis

Pharmacy Focus: Student Edition - Creatives in Pharmacy

One-Third of Adults With Type 2 Diabetes May Have Undetected, Symptomless Cardiovascular Disease

BONUS: American Association of Pharmacy Technicians Convention 2023

FDA Grants Fast Track Designation to Milvexian for Multiple Prospective Cardiovascular Indications

Obstructive Sleep Apnea May Have Significant Impact on Cognitive Decline in Middle-Aged Individuals

Related Content

Acute psoriasis on the elbows is an autoimmune incurable dermatological skin disease. Large red, inflamed, flaky rash on the knees. Joints affected by psoriatic arthritis | Image Credit: SNAB - stock.adobe.com

Efficacy of Upadacitinib Maintained for 3 Years for Those With Psoriatic Arthritis

Pharmacy Focus: Student Edition - Creatives in Pharmacy

Pharmacy Focus: Student Edition - Creatives in Pharmacy

Doctor checking blood sugar level with glucometer. Credit: Proxima Studio - stock.adobe.com

One-Third of Adults With Type 2 Diabetes May Have Undetected, Symptomless Cardiovascular Disease

BONUS: American Association of Pharmacy Technicians Convention 2023

BONUS: American Association of Pharmacy Technicians Convention 2023

3d rendered illustration of heart attack and heart disease 3D illustration | Image Credit: santoelia - stock.adobe.com

FDA Grants Fast Track Designation to Milvexian for Multiple Prospective Cardiovascular Indications

Man sleeping in bed wearing CPAP mask ,sleep apnea therapy.Happy and healthy senior man sleeping deeply on his left side without snoring. Credit: sbw19 - stock.adobe.com

Obstructive Sleep Apnea May Have Significant Impact on Cognitive Decline in Middle-Aged Individuals

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.